Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RET receptor expression and interaction with TRK receptors in neuroblastomas.
Journal: Oncology reports
Published: January 22, 2019
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft Model.
Journal: Molecular cancer therapeutics
Published: September 24, 2018
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.
Journal: Cancer letters
Published: October 26, 2015
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.
Journal: Oncotarget
Published: October 06, 2015
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
Journal: Molecular cancer
Published: April 24, 2015
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.
Journal: The Biochemical journal
Published: April 01, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026